NIHON RIKAGAKU KAIHATSU LLC. – Trademark Portfolio
Entity Type: 16
NIHON RIKAGAKU KAIHATSU LLC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BACTESTER.
35-18, Ogusu 1-chome,
Minami-ku, Fukuoka-shi Fukuoka 815-0082
Showing of trademarks Trademarks
Trademark Classifications
NIHON RIKAGAKU KAIHATSU LLC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does NIHON RIKAGAKU KAIHATSU LLC. have?
NIHON RIKAGAKU KAIHATSU LLC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does NIHON RIKAGAKU KAIHATSU LLC. file in?
NIHON RIKAGAKU KAIHATSU LLC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are NIHON RIKAGAKU KAIHATSU LLC.'s most well-known trademarks?
NIHON RIKAGAKU KAIHATSU LLC.'s registered trademark portfolio includes well-known marks such as BACTESTER. These are among 1 currently registered trademark in the portfolio.
What is NIHON RIKAGAKU KAIHATSU LLC.'s trademark registration success rate?
NIHON RIKAGAKU KAIHATSU LLC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.